TY - JOUR
T1 - Germline mutation and aberrant transcripts of WWOX in a syndrome with multiple primary tumors
AU - Xu, Ao
AU - Wang, Wei
AU - Nie, Jinfu
AU - Lui, Vivian W.Y.
AU - Hong, Bo
AU - Lin, Wenchu
N1 - Funding Information:
This study was supported by National Natural Science Foundation of China (Grant Numbers: 81872438, 81702954, 81672647, 81502632, and 81372214), Natural Science Foundation of Anhui Province (Grant Number: 1608085MH179), Science and Technology Service Network Initiative of Chinese Academy of Sciences (Grant Number: KFJ-STS-SCYD-010), Science and Technology Major Project of Anhui Province (Grant Number: 18030801140), Key program of 13th five-year plan of CASHIPS (Grant Number: KP-2017-26), and the 100-Talent Program of Chinese Academy of Sciences. VWYL is funded by the Research Grant Council, Hong Kong (General Research Fund #17114814, #17121616, #14168517; Theme-based Research Scheme: T12-401/13-R), Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region (HMRF #15160691), University Industry Collaboration Fund (UIM/329) by Lee’s Pharmaceutical and the Innovation and Technology Fund, The Hong Kong Government; the Hong Kong Cancer Fund, and the Start-up Fund from the School of Biomedical Sciences, the Chinese University of Hong Kong, Hong Kong SAR.
Funding Information:
This study was supported by National Natural Science Foundation of China (Grant Numbers: 81872438, 81702954, 81672647, 81502632, and 81372214), Natural Science Foundation of Anhui Province (Grant Number: 1608085MH179), Science and Technology Service Network Initiative of Chinese Academy of Sciences (Grant Number: KFJ-STS-SCYD-010), Science and Technology Major Project of Anhui Province (Grant Number: 18030801140), Key program of 13th five-year plan of CASHIPS (Grant Number: KP-2017-26), and the 100-Talent Program of Chinese Academy of Sciences. VWYL is funded by the Research Grant Council, Hong Kong (General Research Fund #17114814, #17121616, #14168517; Theme-based Research Scheme: T12-401/13-R), Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region (HMRF #15160691), University Industry Collaboration Fund (UIM/329) by Lee's Pharmaceutical and the Innovation and Technology Fund, The Hong Kong Government; the Hong Kong Cancer Fund, and the Start-up Fund from the School of Biomedical Sciences, the Chinese University of Hong Kong, Hong Kong SAR.
Publisher Copyright:
© 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
PY - 2019/9
Y1 - 2019/9
N2 - Multiple primary tumors are defined by the presence of two or more independent primary tumors in the same or different organs of an individual patient. However, the underlying genetic cause for the development of multiple primary tumors is largely unknown. In the study, we report a rare case with four synchronous distinct histological cancer types in a 26 years old Chinese female. In the patient, whole-exome sequencing identified a homozygous germline insertion mutation in WWOX which encodes the DNA repair-related enzyme, WW domain containing oxidoreductase. The mutation was found in a heterozygous state in her parents and brother without any cancer phenotype thus far. Surprisingly, we found multiple novel aberrant WWOX transcripts in the patient's normal colon tissue. The patient's colon metastasis from clear cell adenocarcinoma of the ovary showed a nonhypermutated profile enriched for C-T transition, and harbored somatic pathogenic mutations of HRAS, BRCA2, SMAD4, CHEK2, and AKT1 genes. To our knowledge, this is the first study reporting WWOX gene aberrations in a young patient with the early occurrence of multiple primary tumors.
AB - Multiple primary tumors are defined by the presence of two or more independent primary tumors in the same or different organs of an individual patient. However, the underlying genetic cause for the development of multiple primary tumors is largely unknown. In the study, we report a rare case with four synchronous distinct histological cancer types in a 26 years old Chinese female. In the patient, whole-exome sequencing identified a homozygous germline insertion mutation in WWOX which encodes the DNA repair-related enzyme, WW domain containing oxidoreductase. The mutation was found in a heterozygous state in her parents and brother without any cancer phenotype thus far. Surprisingly, we found multiple novel aberrant WWOX transcripts in the patient's normal colon tissue. The patient's colon metastasis from clear cell adenocarcinoma of the ovary showed a nonhypermutated profile enriched for C-T transition, and harbored somatic pathogenic mutations of HRAS, BRCA2, SMAD4, CHEK2, and AKT1 genes. To our knowledge, this is the first study reporting WWOX gene aberrations in a young patient with the early occurrence of multiple primary tumors.
KW - WWOX
KW - aberrant transcripts
KW - colon and ovarian cancers
KW - germline mutation
KW - multiple primary tumors
UR - http://www.scopus.com/inward/record.url?scp=85067502975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067502975&partnerID=8YFLogxK
U2 - 10.1002/path.5288
DO - 10.1002/path.5288
M3 - Article
C2 - 31056747
AN - SCOPUS:85067502975
SN - 0022-3417
VL - 249
SP - 19
EP - 25
JO - Investigative and Cell Pathology
JF - Investigative and Cell Pathology
IS - 1
ER -